Tag: Cancer: Leukemia
FDA Approves New Treatment for Acute Myeloid Leukemia
Vyxeos combines two previously approved drugs -- daunorubicin and cytarabine
FDA Approves Idhifa for Some With Acute Myeloid Leukemia
For adults with relapsed or refractory AML who have an IDH2 genetic mutation
FDA Approves Imbruvica to Treat Chronic Graft Versus Host Disease
Drug sanctioned for patients with cGVHD who do not respond to other forms of therapy
Potential First U.S. Gene Therapy Now Under FDA Review
Tisagenlecleucel could be a one-time treatment for children and young adults with advanced leukemia
Longer Survival for Midostaurin + Chemotherapy in AML With FLT3
Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation
FDA Approves Kinase Inhibitor for Treatment of AML
Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults
Psoriasis May Up Risk of Melanoma, Hematologic Cancer
No differences in risk observed for type of psoriasis therapy, including systemic or biologic medications
Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group
Blinatumomab Linked to Longer Survival in Adults With ALL
Significantly longer overall, event-free survival for relapsed, refractory B-cell precursor ALL
Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants
Modified T cells from healthy donor allowed infants to reach remission, researchers report
